Retinal Progenitor Differentiation Protocol

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for differentiating human pluripotent stem cells into retinal progenitors, RPE cells, and neural retinal cells are inefficient, complex, and lack reliability, requiring multiple steps and costly media, which hinders the development of effective treatments for retinal degenerative diseases.

Innovation Solution

A novel protocol combining 2D and 3D culture systems that avoids embryoid body formation and the use of matrigel or serum, allowing human pluripotent stem cells to differentiate into neuroepithelial-like structures and subsequently into major retinal cell types, including RPE and photoreceptors, using a pro-neural medium that omits noggin, Dkk-1, and IGF-1, facilitating rapid and efficient generation of retinal cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional differentiation protocols are used to obtain retinal progenitors from human pluripotent stem cells, then retinal cells can be generated, but the process requires multiple steps, addition of several molecules, and is rather inefficient

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidprotocol complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates unnecessary components from the conventional differentiation protocol. Specifically, it removes the requirement for embryoid body formation, matrigel coating, and serum supplementation, simplifying the system to essential elements only (basic medium + pro-neural factors) while maintaining high differentiation efficiency into retinal progenitors

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The differentiation protocol is segmented into distinct phases: (1) pro-neural differentiation phase to generate neuroepithelial-like structures, and (2) retinal specification phase to obtain retinal progenitors. This segmentation allows optimization of each phase independently and enables flexible timing for harvesting different cell types

Inventive Principle:
Principle #1Segmentation

2Productivity

If matrigel and serum are used in the culture medium to support pluripotent stem cell differentiation, then cell growth and differentiation are enhanced, but the cost increases and the protocol becomes more complex

Engineering Contradiction:
Improvecell yieldVSAvoidprotocol simplicity
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The invention replaces expensive, complex materials (matrigel and serum) with a simple, defined, and inexpensive culture medium formulation. The pro-neural medium uses readily available components that are stable and do not require special handling, making the protocol easier to manufacture and implement while maintaining high cell yield

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention changes the chemical parameters of the culture medium by defining specific pro-neural factors and their concentrations, replacing the undefined composition of serum and matrigel. This parameter definition simplifies quality control, reduces variability, and eliminates the need for complex material preparation

Inventive Principle:
Principle #35Parameter changes

3Reliability

If embryoid body formation is used to differentiate pluripotent stem cells into retinal cells, then neural retinal lineage cells can be obtained, but the process takes longer and is less efficient

Engineering Contradiction:
Improvedifferentiation reliabilityVSAvoiddifferentiation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The invention performs preliminary pro-neural differentiation of pluripotent stem cells to generate neuroepithelial-like structures before committing to retinal lineage specification. This preliminary action pre-conditions the cells for efficient retinal differentiation, reducing the overall time required while maintaining reliability

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention skips the time-consuming embryoid body formation step by directly differentiating adherent pluripotent stem cells into neuroepithelial-like structures using pro-neural medium. This shortcut eliminates a entire developmental stage without compromising the ability to generate retinal progenitors

Inventive Principle:
Principle #21Skipping (Rushing through)

Data Source

PatentEP2989200B1Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
Publication Date: 2021.01.20 CENT NAT DE LA RECH SCI (C N R S)
  • EP2989200B1 patent drawingFigure 1A~1G
  • EP2989200B1 patent drawingFigure 1H~1L
  • EP2989200B1 patent drawingFigure 2A~2D

AI summary

The present invention pertains to a method for in vitro obtaining human retinal progenitors, comprising the steps of (i) placing an adherent culture of human pluripotent stem cells in a pro-neural medium; and (ii) maintaining this culture in said pro-neural medium until the appearance of pigmented cells and/or of neuroepithelial-like structures. Advantageously, additional steps can be perfonned to obtain RPE cells and/or precursors of the neural retina.